Difficulty: Medium
Average Score: 71%
Practice
A 29-year-old male patient is being treated with an antidepressant drug, and his mood is improving. However, he complains of feeling 'jittery' and agitated at times, and if he takes his medication in the afternoon he finds it difficult to get to sleep at night. He seems to have lost weight during the 6 months that he has been taking the drug. He has been warned not to take other drugs without consultation because severe reactions have occurred with opioid analgesics including meperidine. This patient is probably taking
Correct answer
C
Rationale
Paroxetine, an SSRI, treats depression by inhibiting serotonin reuptake, often improving mood. Its side effects include agitation and insomnia (especially if taken late), due to serotonin's stimulating effects, and weight loss can occur initially, unlike TCAs which cause gain. A critical clue is the warning against opioids like meperidine: SSRIs can cause serotonin syndrome when combined with MAOIs or other serotonergic drugs, though meperidine's risk is notable in polypharmacy. Alprazolam, a benzodiazepine, sedates rather than agitates. Chlorpromazine, an antipsychotic, causes sedation and weight gain. Amitriptyline, a TCA, is sedating and linked to weight gain, not loss. Trazodone promotes sleep. Paroxetine's profile├óÔé¼ÔÇØactivation, insomnia, weight loss, and drug interaction risks├óÔé¼ÔÇØmatches the patient's experience.